Nav: Home

Researchers diversify drug development options with new metal catalyst

January 09, 2019

CHAMPAIGN, Ill. -- A University of Illinois team of researchers led by chemistry professor M. Christina White has developed a new manganese-based catalyst that can change the structure of druglike molecules to make new drugs, advancing the pace and efficiency of drug development.

Their findings appear in the journal Nature Chemistry.

Many pharmaceuticals contain aliphatic and aromatic carbon-hydrogen scaffolds to which chemists introduce oxygen atoms in precise locations to dictate the behavior of the drug. Aliphatic molecules have carbon-hydrogen bonds that are strong, ubiquitous and difficult to manipulate without affecting other, more reactive parts of the molecule. For example, aromatics have a type of bond that is often more reactive than aliphatic carbon-hydrogen bonds.

"Nature tells us in examples of drugs such as erythromycin and Taxol that by swapping out specific hydrogen atoms with oxygen atoms at strategic locations, chemists can control the function of a drug," White said. "However, carbon-hydrogen bonds in aliphatic structures are some of the strongest in nature, and our previously developed methods to convert them to carbon-oxygen bonds - a process called oxidation - tend not to tolerate aromatics, which also are very prevalent in drugs."

"We have developed a synthetic manganese catalyst that can oxidize aliphatic scaffolds in the presence of aromatics that serve as frameworks for most drugs," White said. White often refers to what her group does as "molecular surgery." Think of this manganese catalyst as analogous to a saw that can cut the skull without touching the brain, she said.

"Our new catalyst does the work of a complex enzyme, but is a simple substance that uses basic principles and can be stored in a refrigerator," she said. "It will allow drug developers to replace a hydrogen atom with an oxygen atom without having to make a new drug from scratch."

The team has used the new manganese catalyst to successfully demonstrate oxidation in 50 molecules, four of which are drug scaffolds, with the potential to rapidly produce derivatives having different biological activities or metabolites. This is important because metabolites - the byproducts of metabolizing a drug - sometimes cause side effects or are more active than the original drug, White said.

"Moving forward, we believe this catalyst may enable chemists to expedite the drug discovery process by producing new drugs from old ones and identifying metabolites without having to do new syntheses," she said.
-end-
The National Institutes of Health, Uehara Memorial Foundation and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico supported this research.

Editor's notes: To reach M. Christina White, call 217-333-6173; mcwhite7@illinois.edu. The paper "Chemoselective methylene oxidation in aromatic molecules" is available online and from the U. of I. News Bureau. DOI: 10.1038/s41557-018-0175-8.

University of Illinois at Urbana-Champaign

Related Metabolites Articles:

Hormone therapy linked to decrease level of diabetes biomarkers
The Women's Health Initiative (WHI) remains one of the most highly quoted when debating the benefits and risks of hormone therapy.
Sugar alters compounds that impact brain health in fruit flies
When fruit flies are exposed to a high sugar diet, key metabolites associated with brain health become depleted, according to a University of Michigan study.
University of Alberta researchers discover new biomarker for rare autoimmune disease
University of Alberta researchers have identified a unique biological marker that can be used to identify the presence of the rare autoimmune disease myasthenia gravis, predict the course of the disease and identify new, personalized treatments.
Scientists identified the metabolic features specific to the autistic brain
Skoltech scientists looked into the differences in the concentrations of multiple metabolites in healthy humans and individuals suffering from Autism Spectrum Disorder (ASD), gaining a deeper insight into the molecular processes that take place in the brain of autistic individuals.
Researchers save images not with a microchip, but with metabolites
An anchor, an ibex and an Egyptian cat: all images that a research team from Brown University, led by Jacob Rosenstein, encoded and decoded from mixtures of small molecules called metabolites.
More Metabolites News and Metabolites Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...